Modulating α-synuclein misfolding and fibrillation in vitro by agrochemicals
暂无分享,去创建一个
[1] J. N. Rao,et al. Characterization of alpha-synuclein interactions with selected aggregation-inhibiting small molecules. , 2008, Biochemistry.
[2] Vladimir N. Uversky,et al. Neuropathology, biochemistry, and biophysics of α‐synuclein aggregation , 2007 .
[3] N. Scott,et al. Environmental risk factors for Parkinson’s disease and parkinsonism: the Geoparkinson study , 2007, Occupational and Environmental Medicine.
[4] F. Coppedè,et al. Genes and the Environment in Neurodegeneration , 2006, Bioscience reports.
[5] J. Doherty. Screening Pesticides for Neuropathogenicity , 2006, Journal of biomedicine & biotechnology.
[6] E. Louis,et al. Organochlorine pesticide exposure in essential tremor: a case-control study using biological and occupational exposure assessments. , 2006, Neurotoxicology.
[7] M. Cookson,et al. Intersecting pathways to neurodegeneration in Parkinson's disease: Effects of the pesticide rotenone on DJ-1, α-synuclein, and the ubiquitin–proteasome system , 2006, Neurobiology of Disease.
[8] A. Fink,et al. Characterization of Oligomeric Intermediates in α-Synuclein Fibrillation: FRET Studies of Y125W/Y133F/Y136F α-Synuclein , 2005 .
[9] C. Ionescu-Zanetti,et al. Mechanism of thioflavin T binding to amyloid fibrils. , 2005, Journal of structural biology.
[10] Andrew B West,et al. Molecular pathophysiology of Parkinson's disease. , 2005, Annual review of neuroscience.
[11] Vladimir N. Uversky,et al. Forcing Nonamyloidogenic β-Synuclein To Fibrillate† , 2005 .
[12] E. Richfield,et al. Developmental Pesticide Models of the Parkinson Disease Phenotype , 2005, Environmental health perspectives.
[13] J. Andersen,et al. Role of oxidative stress in paraquat‐induced dopaminergic cell degeneration , 2005, Journal of neurochemistry.
[14] Ad Bax,et al. Structure and Dynamics of Micelle-bound Human α-Synuclein* , 2005, Journal of Biological Chemistry.
[15] M. Emborg. Evaluation of animal models of Parkinson's disease for neuroprotective strategies , 2004, Journal of Neuroscience Methods.
[16] Vladimir N. Uversky,et al. Neurotoxicant-induced animal models of Parkinson’s disease: understanding the role of rotenone, maneb and paraquat in neurodegeneration , 2004, Cell and Tissue Research.
[17] A. Schober,et al. Genes, proteins, and neurotoxins involved in Parkinson’s disease , 2004, Progress in Neurobiology.
[18] P. Crooks,et al. Toxicity of Dipyridyl Compounds and Related Compounds , 2004, Critical reviews in toxicology.
[19] T. Yagi,et al. Mechanism of Toxicity in Rotenone Models of Parkinson's Disease , 2003, The Journal of Neuroscience.
[20] V. Uversky,et al. Conformational behavior and aggregation of alpha-synuclein in organic solvents: modeling the effects of membranes. , 2003, Biochemistry.
[21] C. Stichel,et al. The mouse MPTP model: gene expression changes in dopaminergic neurons , 2003, The European journal of neuroscience.
[22] Kiowa S. Bower,et al. Synergistic effects of pesticides and metals on the fibrillation of alpha-synuclein: implications for Parkinson's disease. , 2002, Neurotoxicology.
[23] J. Langston,et al. Environmental Risk Factors and Parkinson's Disease: Selective Degeneration of Nigral Dopaminergic Neurons Caused by the Herbicide Paraquat , 2002, Neurobiology of Disease.
[24] V. Uversky,et al. Methionine oxidation inhibits fibrillation of human α‐synuclein in vitro , 2002 .
[25] V. Uversky,et al. The Herbicide Paraquat Causes Up-regulation and Aggregation of α-Synuclein in Mice , 2002, The Journal of Biological Chemistry.
[26] V. Uversky,et al. Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure. , 2001, The Journal of biological chemistry.
[27] V. Uversky,et al. Stabilization of Partially Folded Conformation during α-Synuclein Oligomerization in Both Purified and Cytosolic Preparations* , 2001, The Journal of Biological Chemistry.
[28] K. Matsubara,et al. Carrier-mediated processes in blood–brain barrier penetration and neural uptake of paraquat , 2001, Brain Research.
[29] V. Uversky,et al. Pesticides directly accelerate the rate of α‐synuclein fibril formation: a possible factor in Parkinson's disease , 2001, FEBS letters.
[30] N. Inestrosa,et al. Thioflavin T Is a Fluorescent Probe of the Acetylcholinesterase Peripheral Site That Reveals Conformational Interactions between the Peripheral and Acylation Sites* , 2001, The Journal of Biological Chemistry.
[31] V. Uversky,et al. Is Congo Red an Amyloid-specific Dye?* , 2001, The Journal of Biological Chemistry.
[32] V. Uversky,et al. Probing the mechanism of insulin fibril formation with insulin mutants. , 2001, Biochemistry.
[33] V. Uversky,et al. Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism. , 2001, Biochemistry.
[34] V. Uversky,et al. Evidence for a Partially Folded Intermediate in α-Synuclein Fibril Formation* , 2001, The Journal of Biological Chemistry.
[35] E. Richfield,et al. Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson’s disease? , 2000, Brain Research.
[36] B. Ritz,et al. Parkinson's disease mortality and pesticide exposure in California 1984-1994. , 2000, International journal of epidemiology.
[37] C. L. Wienburg,et al. Organochlorine insecticides in substantia nigra in Parkinson's disease. , 2000, Journal of toxicology and environmental health. Part A.
[38] P. Lansbury,et al. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid. , 2000, Biochemistry.
[39] J. Langston,et al. Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine exposure , 1999, Annals of neurology.
[40] Peter T. Lansbury,et al. Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease , 1998, Nature Medicine.
[41] G. Nisticó,et al. Paraquat: a useful tool for the in vivo study of mechanisms of neuronal cell death. , 1998, Pharmacology & toxicology.
[42] V. Uversky,et al. Structural effect of association on protein molecules in partially folded intermediates. , 1998, Biochemistry. Biokhimiia.
[43] A. Fink,et al. A new attenuated total reflectance Fourier transform infrared spectroscopy method for the study of proteins in solution. , 1998, Analytical biochemistry.
[44] H. Levine. Soluble multimeric Alzheimer β(1–40) pre-amyloid complexes in dilute solution , 1995, Neurobiology of Aging.
[45] R. Hales,et al. J Neuropsychiatry Clin Neurosci , 1992 .
[46] M. Hosokawa,et al. Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1. , 1989, Analytical biochemistry.
[47] J. Langston,et al. Selective accumulation of MPP+ in the substantia nigra: a key to neurotoxicity? , 1985, Life sciences.
[48] J. Langston,et al. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. , 1983, Science.
[49] J. Parkinson. AN ESSAY ON THE SHAKING PALSY , 1969 .
[50] Vladimir N Uversky,et al. Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation. , 2007, Journal of neurochemistry.
[51] R. Murphy,et al. Misbehaving proteins : protein (mis)folding, aggregation, and stability , 2006 .
[52] Vladimir N Uversky,et al. Forcing nonamyloidogenic beta-synuclein to fibrillate. , 2005, Biochemistry.
[53] Dong-Pyo Hong,et al. Characterization of oligomeric intermediates in alpha-synuclein fibrillation: FRET studies of Y125W/Y133F/Y136F alpha-synuclein. , 2005, Journal of molecular biology.
[54] V. Uversky,et al. Methionine oxidation inhibits fibrillation of human alpha-synuclein in vitro. , 2002, FEBS letters.
[55] V. Uversky,et al. The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein. , 2002, The Journal of biological chemistry.
[56] James Parkinson,et al. An essay on the shaking palsy. 1817. , 2002, The Journal of neuropsychiatry and clinical neurosciences.
[57] H. Levine. Soluble multimeric Alzheimer beta(1-40) pre-amyloid complexes in dilute solution. , 1995, Neurobiology of aging.
[58] A. Fink,et al. Methods for collecting and analyzing attenuated total reflectance FTIR spectra of proteins in solution , 1995 .
[59] K. Matsushima,et al. Fluorometric examination of tissue amyloid fibrils in murine senile amyloidosis: use of the fluorescent indicator, thioflavine T. , 1990, Laboratory investigation; a journal of technical methods and pathology.